-
1.发明公开
公开(公告)号：EP3534713A2
公开(公告)日：2019-09-11
申请号：EP17866592.3
申请日：2017-11-02
发明人： ANVERSA, Piero , LERI, Annarosa
IPC分类号： A01N63/00 , C12N5/071 , C12N5/02 , C12P1/00 , G01N33/567
-
公开(公告)号：EP2498796B1
公开(公告)日：2017-12-27
申请号：EP10829273.1
申请日：2010-11-09
发明人： ANVERSA, Piero , KAJSTURA, Jan , LERI, Annarosa
CPC分类号： A61K35/34 , A61K35/12 , C12N5/0657 , C12N5/0662 , C12N2501/105
摘要： Disclosed herein are methods, compositions and kits for treating cardiac stem cells to be administered to a subject in need thereof, e.g., with a damaged myocardium. The methods, composition and kits of the invention can be used to treat cardiovascular diseases such as heart failure, myocardial infarction and an age-related cardiomyopathy.
-
公开(公告)号：EP2624847B1
公开(公告)日：2017-09-13
申请号：EP11831492.1
申请日：2011-10-05
发明人： ANVERSA, Piero , PERRELLA, Mark , LERI, Annarosa , KAJSTURA, Jan
CPC分类号： A61K35/42 , A61K45/06 , C12N5/0689
摘要： Embodiments of the invention relate to human stem cells and their therapeutic use in the treatment and/or prevention of lung diseases. Provided herein are compositions comprising c-kit positive human lung stem cells and methods of preparing and using c-kit positive human lung stem cells for the treatment and/or prevention of lung diseases.
摘要翻译： 本发明的实施方案涉及人类干细胞及其在治疗和/或预防肺部疾病中的治疗用途。 本文提供了包含c-kit阳性人肺干细胞的组合物以及制备和使用c-kit阳性人肺干细胞用于治疗和/或预防肺疾病的方法。
-
公开(公告)号：EP3426268A1
公开(公告)日：2019-01-16
申请号：EP17763966.3
申请日：2017-03-08
发明人： ANVERSA, Piero
IPC分类号： A61K35/39
-
-
-
-
搜索结果
5 条记录 (耗时 0.012 秒)
